Erinna is a Hormonal Intrauterine System that comes with no applicator. It consists of a frame with a drug reservoir containing 52mg of the levonorgestrel (LNG) hormone, releasing a daily dose of 20µg of the hormone into the uterine cavity. The reservoir is encased in a rate-limiting membrane that controls the release kinetics of the hormone so that the prescribed dose of it is released daily for up to 5 years.

Key Features

Reduces menstrual bleeding and cramps after the first few months of implantation, eventually causing menstrual periods to stop altogether.

May prevent endometrial hyperplasia or endometrial cancer.

May effectively relieve endometriosis and is less likely to cause side effects than high-dose progestin.

Does not cause weight gain.

  • LNG thickens the cervical mucus that prevents sperm to enter the uterine cavity.
  • The physical presence of a T-frame prevents the entry of sperm into the fallopian tubes.
  • LNG also helps in thinning the endometrial lining thereby preventing conception.

Indication

Contraception for 5 years
Aids in treating patients with menorrhagia/dysfunctional uterine bleeding(DUB)/abnormal uterine bleeding(AUB).

Other Products

Merite Cu 375

Merite Cu 375

Fiona™

Fiona™

MeriTe Cu 250

MeriTe Cu 250

1 / 4

Connect with Meril

Logo
Careers
About Us
Research & Development
Our Products
Innovation
Knowledge
Meril Academy
Patient Awareness
Contact
Press & Media
Blogs
Disclaimer
Privacy Policy
Follow us on
LinkedInFacebookYouTubeInstagramInstagram